Quick Takeaways
- Scott Koenig has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,764,799.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Scott Koenig
- Location
- Rockville, MD
- Summary
- The estimated net worth of Scott Koenig is at least $1,764,799 dollars as of 17 Feb 2026. Scott Koenig is the Director of MACROGENICS INC and owns shares of MACROGENICS INC (MGNX) stock worth about $1.68M. Scott Koenig is the Director of GLYCOMIMETICS INC and owns shares of CRESCENT BIOPHARMA, INC. (CBIO) stock worth about $86.7K.
- Signature
- /s/ Beth A. Smith, Attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Scott Koenig and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: MACROGENICS INC ($1,678,069).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Scott Koenig
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MGNX | MACROGENICS INC | Director | $1,678,069 | 15 Feb 2026 | ||
| CBIO | GLYCOMIMETICS INC | Director | $86,730 | 01 May 2024 | ||
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Director | 30 Nov 2022 |
Insider Transactions Reported by Scott Koenig:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.